RankAlpha logo
Back to Rankings

NAMS

NewAmsterdamF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-22
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
NAMS vs peer average
22/100
NAMS vs. peer average (F vs. C)
Grade spread
B 2 · C 3 · D 2 · F 1
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

ALMS is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $3.67B

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerALMSAlumis
NAMS
NewAmsterdam
ALMS
Alumis
Grade
F
B
Momentum
21
94
Value
41
41
Sentiment
-
48
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs ALMS

NAMS / ALMS
Grade Position
Below peers
NAMS vs. peer average (F vs. C)
22/100
Momentum
21
ALMS
Value
41
NAMS
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs NAMS
1
ALMS
Alumis Inc Common
B
80/100
-3
2
DNLI
Denali Therapeutics Inc Common
C
60/100
-2
3
RCUS
Arcus Biosciences Inc Common
C
60/100
-2
4
ELVN
Enliven Therapeutics Inc Common
D
40/100
-1
5
GPCR
Structure Therapeutics Inc ADR
D
40/100
-1
ALMS is the first peer returned for this comparison set.